Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

RKDA Arcadia Biosciences, Inc.
$1.80 -6.77% -0.13
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RKDA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.9M
Enterprise value -3413384
Trailing PE -0.34816246659889
Forward PE -1.40625
PEG Ratio 0.0022697884562801
Enterprise to EBITDA 0.574
Enterprise to revenue -0.66
Price to book MRQ 0.4522613
Price to sales TTM 0.7591508

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 5.2M
EBITDA -5949000
Diluted EPS TTM -3.69
Total Cash (MRQ) 5.9M
Current ratio (MRQ) 3.67
Operating Cash Flow (TTM) -6087000

RKDA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent RKDA News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.